Renata Berardocco, Executive Vice President and Managing Director for the Latin America region at Velocity Clinical Research
Velocity apunta a la expansión en América Latina con el nombramiento de Renata Berardocco como directora general para LATAM
21 nov. 2024 07h04 HE | Velocity Clinical Research, Inc.
DURHAM, Carolina del Norte, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research, la organización líder de centros clínicos totalmente integrados, anuncia el nombramiento de Renata...
Renata Berardocco, Executive Vice President and Managing Director for the Latin America region at Velocity Clinical Research
Velocity mira expansão na América Latina com a nomeação de Renata Berardocco como Diretora Geral da América Latina
21 nov. 2024 07h04 HE | Velocity Clinical Research, Inc.
DURHAM, Carolina do Norte, Nov. 21, 2024 (GLOBE NEWSWIRE) -- A Velocity Clinical Research, organização líder do mercado no segmento de centros clínicos totalmente integrados, anuncia a nomeação de...
Renata 3
Velocity targets Latin America expansion with the appointment of Renata Berardocco as LATAM Managing Director
21 nov. 2024 07h04 HE | Velocity Clinical Research, Inc.
DURHAM, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research, the leading fully integrated clinical site organization, announces the appointment of Renata Berardocco as Executive Vice...
Rachael Buck
Velocity appoints ICON exec Rachael Buck Ph.D. as Head of U.K.
07 août 2024 07h06 HE | Velocity Clinical Research, Inc.
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, today announces the appointment of Rachael Buck Ph.D. as...
Mike Zaranek
Velocity appoints ex-IQVIA and Science 37 Executive Mike Zaranek as CFO
16 juil. 2024 07h04 HE | Velocity Clinical Research, Inc.
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, today announces it has appointed Mike Zaranek as Chief...
Velocity President and Chief Executive, Dr Paul Evans
Velocity Clinical Research partners with Luminis Health, moves into oncology in the U.S.
12 juin 2024 07h03 HE | Velocity Clinical Research, Inc.
DURHAM, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, and Luminis Health, a non-profit health system providing...
PaulEvans_VCR01339_FINAL_WorkshopMedia_VelocityClinicalResearch_DallasLeadershipHeadshots2022_WMVC-150 (6) (2)
nmible partners with Velocity Clinical Research to streamline clinical trials patient stipends
24 janv. 2024 08h05 HE | Velocity Clinical Research, Inc.
•  nmible’s solution expected to save more than 650 working days per year, administering payments •  Velocity spends $20 million a year in patient stipends LONDON, Jan. 24, 2024 (GLOBE NEWSWIRE)...
Introducing_Vision
Velocity Clinical Research transforms patient experience and recruitment with VISION technology platform
09 janv. 2024 07h01 HE | Velocity Clinical Research, Inc.
• App downloads surpassed 25,000 • First time a clinical trials site business has developed end-to-end system for patients DURHAM, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical...
Velocity expandiert auf 17 Standorte in Europa
04 janv. 2024 03h00 HE | Velocity Clinical Research, Inc.
Velocity wird zu einem der größten Netzwerke von Prüfzentren in Europa und ist außerdem das größte in den USA.Erweitert die therapeutischen Möglichkeiten um den Bereich Onkologie LONDON, Jan. 04,...
Velocity rozszerza swoją działalność na 17 ośrodków w Europie
03 janv. 2024 03h00 HE | Velocity Clinical Research, Inc.
Firma Velocity będąca największą w Stanach Zjednoczonych siecią ośrodków badań klinicznych staje się również jedną z największych sieci ośrodków badań klinicznych w Europie.Dodaje onkologię do...